1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 79 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Colorectal cancer treatment and survival : the experience of major public hospitals in South Australia over three decadesRoder, D.; Karapetis, C.; Wattchow, D.; Moore, J.; Singhal, N.; Joshi, R.; Keefe, D.; Fusco, K.; Powell, K.; Eckert, M.; Price, T.
2013Hepatic encephalopathy associated with cancer or anticancer therapyWillson, K.; Nott, L.; Broadbridge, V.; Price, T.
2013A descriptive study of persistent oxaliplatin induced peripheral neuropathy in patients with colorectal cancerVatandoust, S.; Joshi, R.; Pittman, K.; Esterman, A.; Broadbridge, V.; Adams, J.; Singhal, N.; Yeend, S.; Price, T.; Medical Oncology Group of Australia Incorporated Annual Scientific Meeting (31 Jul 2013 - 2 Aug 2013 : Melbourne, Victoria)
2015Detection and clinical significance of circulating tumor cells in colorectal cancer - 20 years of progressHardingham, J.; Grover, P.; Winter, M.; Hewett, P.; Price, T.; Thierry, B.
2014Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cellsWan, Y.; Winter, M.; Delalat, B.; Hardingham, J.; Grover, P.; Wrin, J.; Voelcker, N.; Price, T.; Thierry, B.
2015Rising incidence of early-onset colorectal cancer in Australia over two decades: Report and reviewYoung, J.; Win, A.; Rosty, C.; Flight, I.; Roder, D.; Young, G.; Frank, O.; Suthers, G.; Hewett, P.; Ruszkiewicz, A.; Hauben, E.; Adelstein, B.; Parry, S.; Townsend, A.; Hardingham, J.; Price, T.
2014The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17Sommeijer, D.; Karapetis, C.; Zalcberg, J.; Tu, D.; Jonker, D.; Simes, J.; Tebbutt, N.; Yip, D.; Price, T.; O'Callaghan, C.
2016Fc-γ receptor polymorphisms, cetuximab therapy, and survival in the NCIC CTG CO.17 trial of colorectal cancerLiu, G.; Tu, D.; Lewis, M.; Cheng, D.; Sullivan, L.; Chen, Z.; Morgen, E.; Simes, J.; Price, T.; Tebbutt, N.; Shapiro, J.; Jeffery, G.; Mellor, J.; Mikeska, T.; Virk, S.; Shepherd, L.; Jonker, D.; O'Callaghan, C.; Zalcberg, J.; Karapetis, C.; et al.
2014Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancerHocking, C.; Price, T.
2016Advances in molecular pathology and treatment of periampullary cancersChandrasegaram, M.; Chen, J.; Price, T.; Zalcberg, J.; Sjoquist, K.; Merrett, N.

Discover